Eterna Therapeutics Inc
NASDAQ:ERNA

Watchlist Manager
Eterna Therapeutics Inc Logo
Eterna Therapeutics Inc
NASDAQ:ERNA
Watchlist
Price: 1.31 USD 3.97% Market Closed
Market Cap: 10.3m USD

Wall Street
Price Targets

ERNA Price Targets Summary
Eterna Therapeutics Inc

There are no price targets for ERNA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Eterna Therapeutics Inc Competitors:
Price Targets
NGNE
Neurogene Inc
193% Upside
NTLA
Intellia Therapeutics Inc
140% Upside
301207
Hualan Biological Bacterin Inc
1% Upside
FYB
Formycon AG
111% Upside
SKYE
Skye Bioscience Inc
856% Upside
ADCT
ADC Therapeutics SA
119% Upside

Revenue
Forecast

Revenue Estimate
Eterna Therapeutics Inc

For the last 13 years the compound annual growth rate for Eterna Therapeutics Inc's revenue is -25%.

-25%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Eterna Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Eterna Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ERNA's stock price target?
Not Available

ERNA doesn't have any price targets made by Wall Street professionals.

Back to Top